Desh Rakshak Aushdhalaya Ltd.

6.62 ▼0%

23 November 2023, 04:01:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.deshrakshak.in
Market Cap 2.94 Cr.
Enterprise Value(EV) 7.13 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.13 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 5.85 Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 20.40 Trailing Twelve Months Ending 2023-09
Price to Book Value 0.32 Calculated using Price: 6.62
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.44 Cr. 4,438,324 Shares
FaceValue 10
About Desh Rakshak Aushdhalaya Ltd.
The company is the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by its Ancient Seers & Sages. The medicines are categorized into Patent & Proprietary (Classical) Medicines. The company is currently manufacturing around 400 products (Patent and Classical mix). And all these medicines are manufactured as per the prescribed norms and standards of the Indian Government.

Desh Rakshak Aushdhalaya Ltd. Delivery

Delivered Qty
Traded Qty

Desh Rakshak Aushdhalaya Ltd. Performance

1 Day
1 Week
1 Month
+10.15%
3 Month
+10.15%
6 Month
+10.15%
1 Year
+33.47%
2 Year
+69.31%
5 Year
+31.35%
10 Year
-27.65%

Desh Rakshak Aushdhalaya Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.37 4.36 4.03 3.90 4.40 3.83 5.05 5.49 4.54
Return on Capital Employed (%) 2.54 5.98 5.33 5.54 5.99 5.77 6.69 6.44 6.70
Return on Assets (%) 0.26 2.96 2.78 2.69 3.01 2.56 3.12 3.13 2.54

Desh Rakshak Aushdhalaya Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 7 7 7 8 8 8 9 9 9 9
Non Curr. Liab. 1 1 1 1 1 2 3 4 4 4
Curr. Liab. 2 2 2 2 2 2 3 3 3 2
Minority Int.
Equity & Liab. 10 10 10 11 11 12 15 16 16 16
Non Curr. Assets 5 6 6 7 7 8 9 11 11 10
Curr. Assets 5 4 4 4 4 4 5 6 5 5
Misc. Exp. not W/O
Total Assets 10 10 10 11 11 12 15 16 16 16

Desh Rakshak Aushdhalaya Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 4 5 5 5 6 5 7 6 6 6
Other Income 0 0 0 0 0 0 0
Total Income 4 5 5 5 6 5 7 6 6 6
Total Expenditure -4 -4 -4 -4 -5 -4 -6 -5 -5 -5
PBIDT 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 1
Adjusted EPS 0 1 1 1 1 1 1 1 1 1

Desh Rakshak Aushdhalaya Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 1 0 0 -1 1 1 0 0
Cash Fr. Inv. 0 0 -1 -1 0 0 -1 -1 -2 -1
Cash Fr. Finan. 0 1 1 1 0
Net Change 0 0 1 -1 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 1 0 0 0 0 1 0 0

Desh Rakshak Aushdhalaya Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 64.28 64.28 64.28 64.28 64.28 64.28 64.28 64.28 64.28
Public 35.72 35.72 35.72 35.72 35.72 35.72 35.72 35.72 35.72
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Desh Rakshak Aushdhalaya Ltd. Announcements

Thu, 09 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please Find Attached herewith Newspaper Publication of Unaudited Fianncial Results of the company M/s Desh Rakshak Aushdhalaya Limited for the quarter and half year ended on 30th September 2023 as per Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015
Wed, 08 Nov 2023
Non-Applicability Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SSEBI (LODR) Reg 2015 For The Half Year Ended 30Th September 2023
With reference to the above subject the provisions of Regulation 23(9) read with Regulation 15(2) Applicability criteria of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 the provisions mentioned in Reg 29(9) od SEBI(LODR) Reg 2015 relating to submission of related party disclosure on half yearly basis is not applicable to the company
Wed, 08 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 8Th Nov 2023 Pursuant To Para A Of Part A Of Schedule III Read With Reg 30 And 33 Of SEBI (LODR) Reg 2015
Pursuant to Reg 33 of the SEBI (LODR) Reg 2015 the Board approved and/or considered the following: i.The Un-Audited Quarterly & Year to date Financial Results for Quarter and half year ended on 30th Sep 2023 along with Statement of Assets & Liabilities and Cash Flow Statement for the half year ended 30th Sep 2023 ii.The Limited Review Report on the Quarterly & Year to date financial results for the Quarter & half year ended on 30th Sep 2023 iii.Closure of Trading window from 1st Oct 2023 till 48 hours after the declaration of financial results for the Quarter & half year ended 30th Sep 2023

Desh Rakshak Aushdhalaya Ltd. Technical Scans

No Scans Found

Desh Rakshak Aushdhalaya Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,244.25 +0.7%
Cipla Ltd. 98,444.27 1,201.95 -1.4%
Divi's Laboratories Ltd. 97,728.28 3,667.50 -0.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,469.35 -5.1%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,551.00 -0.1%
Mankind Pharma Ltd. 78,250.95 1,924.60 -1.4%
Torrent Pharmaceuticals Ltd. 69,508.23 2,078.35 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,244.25 +0.7%
Cipla Ltd. Consolidated 2023-09 28.51 1,201.95 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,667.50 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,469.35 -5.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,551.00 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,924.60 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,078.35 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,244.25 +0.7%
Cipla Ltd. Consolidated 2023-09 3.97 1,201.95 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,667.50 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,469.35 -5.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,551.00 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,924.60 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,078.35 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,244.25 +0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,201.95 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,667.50 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,469.35 -5.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,551.00 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,924.60 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,078.35 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,244.25 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.95 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,667.50 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,469.35 -5.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,551.00 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,924.60 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,078.35 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,244.25 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.95 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,667.50 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,469.35 -5.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,551.00 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,924.60 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,078.35 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,244.25 +0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,201.95 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,667.50 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,469.35 -5.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,551.00 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,924.60 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,078.35 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,244.25 +0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,201.95 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,667.50 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,469.35 -5.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,551.00 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,924.60 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,078.35 +1.2%

Desh Rakshak Aushdhalaya Ltd. FAQ's

What is Desh Rakshak Aushdh share price?

Can I buy Desh Rakshak Aushdh shares now?

What is the Market Cap of Desh Rakshak Aushdh?

What are the key metrics to analyse Desh Rakshak Aushdh?

What is the 52 Week High and Low of Desh Rakshak Aushdh?